DE602004024538D1 - Sulphonamid benzoxazinonderivate. ihre herstellung und verwendung als medikamente - Google Patents
Sulphonamid benzoxazinonderivate. ihre herstellung und verwendung als medikamenteInfo
- Publication number
- DE602004024538D1 DE602004024538D1 DE602004024538T DE602004024538T DE602004024538D1 DE 602004024538 D1 DE602004024538 D1 DE 602004024538D1 DE 602004024538 T DE602004024538 T DE 602004024538T DE 602004024538 T DE602004024538 T DE 602004024538T DE 602004024538 D1 DE602004024538 D1 DE 602004024538D1
- Authority
- DE
- Germany
- Prior art keywords
- sulphonamide
- medicaments
- preparation
- benzoxazine derivatives
- benzoxazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200301812A ES2232292B1 (es) | 2003-07-30 | 2003-07-30 | Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos. |
PCT/EP2004/008507 WO2005014589A1 (en) | 2003-07-30 | 2004-07-29 | Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004024538D1 true DE602004024538D1 (de) | 2010-01-21 |
Family
ID=34130545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004024538T Active DE602004024538D1 (de) | 2003-07-30 | 2004-07-29 | Sulphonamid benzoxazinonderivate. ihre herstellung und verwendung als medikamente |
Country Status (23)
Country | Link |
---|---|
US (1) | US20070032482A1 (de) |
EP (1) | EP1648886B1 (de) |
JP (1) | JP2007500161A (de) |
KR (1) | KR20060056355A (de) |
CN (1) | CN1860114A (de) |
AR (1) | AR045153A1 (de) |
AT (1) | ATE451366T1 (de) |
AU (1) | AU2004263300A1 (de) |
BR (1) | BRPI0413101A (de) |
CA (1) | CA2534095A1 (de) |
CL (1) | CL2004001929A1 (de) |
DE (1) | DE602004024538D1 (de) |
EC (1) | ECSP066331A (de) |
ES (2) | ES2232292B1 (de) |
IL (1) | IL173004A0 (de) |
MX (1) | MXPA06001228A (de) |
NO (1) | NO20060969L (de) |
PE (1) | PE20050724A1 (de) |
PT (1) | PT1648886E (de) |
RU (1) | RU2006105714A (de) |
TW (1) | TW200510354A (de) |
WO (1) | WO2005014589A1 (de) |
ZA (1) | ZA200600426B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2390057T3 (es) | 2004-04-20 | 2012-11-06 | Amgen Inc. | Arilsulfonilamidas y usos como hidroxiesteroide deshidrogenasa |
AR058277A1 (es) | 2005-12-09 | 2008-01-30 | Solvay Pharm Gmbh | N- sulfamoil - piperidin - amidas, composiciones farmaceuticas que las comprenden y procedimiento para su preparacion |
GB2435825A (en) * | 2006-03-09 | 2007-09-12 | Esteve Labor Dr | Benzimidazole-2- & pyrido[d]imidazole-2- sulphonamide derivatives for treatment of disorders mediated via 5-HT6 receptors, eg those related to food intake |
EP2053052A1 (de) | 2007-10-23 | 2009-04-29 | Laboratorios del Dr. Esteve S.A. | Verfahren zur Herstellung von 6-substituiertem Imidazo[2,1-b]thiazol-5-sulfonylhalogenid |
ES2821877T3 (es) | 2016-07-07 | 2021-04-28 | Bristol Myers Squibb Co | Espirolactamas como inhibidores de ROCK |
GB201713780D0 (en) * | 2017-08-29 | 2017-10-11 | E-Therapeutics Plc | Modulators of hedgehog (Hh) signalling pathway |
CN109232599B (zh) * | 2018-10-08 | 2021-04-20 | 广西中医药大学 | 具有抗肿瘤活性的o-对三氟甲基苯甲酰基土甘草a及其制备方法和用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4344945A (en) * | 1980-03-10 | 1982-08-17 | Kyowa Hakko Kogyo Co., Ltd. | Piperidine derivatives |
TW199153B (de) * | 1990-08-07 | 1993-02-01 | Dtsuka Seiyaku Kk | |
JPH09500134A (ja) * | 1993-07-16 | 1997-01-07 | メルク エンド カンパニー インコーポレーテッド | ベンゾオキサジノンおよびベンゾピリミジノンピペリジニル早産防止オキシトシン受容体拮抗剤 |
PL189256B1 (pl) * | 1996-03-29 | 2005-07-29 | Duphar Int Res | Związki piperazyny i piperydyny, sposób ich wytwarzania, kompozycja farmaceutyczna zawierająca te związki, zastosowanie tych związków do wytwarzania leków |
CZ384698A3 (cs) * | 1996-05-29 | 1999-03-17 | Warner-Lambert Company | Antagonisté dopaminového receptoru D4 na bázi benzoxazinu |
SE9904652D0 (sv) * | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
PT1283838E (pt) * | 2000-05-12 | 2004-04-30 | Solvay Pharm Bv | Compostos de piperazina e de piperidina |
-
2003
- 2003-07-30 ES ES200301812A patent/ES2232292B1/es not_active Expired - Fee Related
-
2004
- 2004-07-29 JP JP2006521525A patent/JP2007500161A/ja active Pending
- 2004-07-29 CA CA002534095A patent/CA2534095A1/en not_active Abandoned
- 2004-07-29 ZA ZA200600426A patent/ZA200600426B/en unknown
- 2004-07-29 AR ARP040102695A patent/AR045153A1/es unknown
- 2004-07-29 AU AU2004263300A patent/AU2004263300A1/en not_active Abandoned
- 2004-07-29 ES ES04741318T patent/ES2338008T3/es active Active
- 2004-07-29 CN CNA2004800280755A patent/CN1860114A/zh active Pending
- 2004-07-29 CL CL200401929A patent/CL2004001929A1/es unknown
- 2004-07-29 RU RU2006105714/04A patent/RU2006105714A/ru unknown
- 2004-07-29 MX MXPA06001228A patent/MXPA06001228A/es active IP Right Grant
- 2004-07-29 KR KR1020067002066A patent/KR20060056355A/ko not_active Application Discontinuation
- 2004-07-29 PT PT04741318T patent/PT1648886E/pt unknown
- 2004-07-29 AT AT04741318T patent/ATE451366T1/de not_active IP Right Cessation
- 2004-07-29 WO PCT/EP2004/008507 patent/WO2005014589A1/en active Application Filing
- 2004-07-29 TW TW093122663A patent/TW200510354A/zh unknown
- 2004-07-29 BR BRPI0413101-0A patent/BRPI0413101A/pt not_active Application Discontinuation
- 2004-07-29 EP EP04741318A patent/EP1648886B1/de active Active
- 2004-07-29 US US10/566,404 patent/US20070032482A1/en not_active Abandoned
- 2004-07-29 DE DE602004024538T patent/DE602004024538D1/de active Active
- 2004-08-02 PE PE2004000733A patent/PE20050724A1/es not_active Application Discontinuation
-
2006
- 2006-01-05 IL IL173004A patent/IL173004A0/en unknown
- 2006-01-30 EC EC2006006331A patent/ECSP066331A/es unknown
- 2006-02-28 NO NO20060969A patent/NO20060969L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0413101A (pt) | 2006-10-03 |
AR045153A1 (es) | 2005-10-19 |
JP2007500161A (ja) | 2007-01-11 |
CN1860114A (zh) | 2006-11-08 |
NO20060969L (no) | 2006-04-11 |
EP1648886A1 (de) | 2006-04-26 |
CA2534095A1 (en) | 2005-01-27 |
ES2232292B1 (es) | 2006-11-01 |
PT1648886E (pt) | 2010-03-10 |
KR20060056355A (ko) | 2006-05-24 |
WO2005014589A1 (en) | 2005-02-17 |
ECSP066331A (es) | 2006-08-30 |
EP1648886B1 (de) | 2009-12-09 |
PE20050724A1 (es) | 2005-11-16 |
ATE451366T1 (de) | 2009-12-15 |
CL2004001929A1 (es) | 2005-06-03 |
TW200510354A (en) | 2005-03-16 |
ZA200600426B (en) | 2007-03-28 |
MXPA06001228A (es) | 2006-05-15 |
ES2338008T3 (es) | 2010-05-03 |
AU2004263300A1 (en) | 2005-02-17 |
ES2232292A1 (es) | 2005-05-16 |
US20070032482A1 (en) | 2007-02-08 |
IL173004A0 (en) | 2006-06-11 |
RU2006105714A (ru) | 2007-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50311318D1 (de) | Neue substituierte imidazo-pyridinone und imidazo-pyridazinone, ihre herstellung und ihre verwendung als arzneimittel | |
DE50312295D1 (de) | 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel | |
DE602006013878D1 (de) | Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel | |
DE60303440D1 (de) | Benzoxazinonderivate, deren herstellung und deren verwendung als medikamente | |
DE602005021501D1 (de) | Sulfonamidderivate, ihre herstellung und ihre therapeutische anwendung | |
DE602005019743D1 (de) | Oxopiperidinderivate, ihre herstellung und therapeutische verwendung | |
DE60209779D1 (de) | Sulfonamidderivate, deren herstellung und deren verwendung als medikamente | |
DE602005026964D1 (de) | 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung | |
DE50209483D1 (de) | Xanthinderivate, deren herstellung und deren verwendung als arzneimittel | |
DE50312747D1 (de) | Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel | |
ATE395342T1 (de) | 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung | |
ATE432701T1 (de) | Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren | |
ATE541843T1 (de) | 2-acylamino-4-phenylthiazolderivate, ihre herstellung und anwendung als chemokin antagonisten | |
ATE467633T1 (de) | 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung | |
DE60200427D1 (de) | Vernetzbare Fluorelastomerzusammensetzungen, ihre Herstellung und Verwendung | |
ATE451923T1 (de) | N-(arylalkyl)-1h-pyrrolopyridin-2-carboxamid- derivate, ihre herstellung und verwendung | |
DE602004021384D1 (de) | Indol-5 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren | |
ATE417846T1 (de) | Aminotropanderivate, deren herstellung und deren therapeutische verwendung | |
DE502005006380D1 (de) | Neue cycloalkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel | |
DE602006002887D1 (de) | Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel | |
ATE396994T1 (de) | 3-phenylpyridoindolderivate, ihre herstellung und verwendung | |
DE602006016258D1 (de) | 4h-1,2,4-triazin-5-on-derivate, ihre herstellung und ihre verwendung als alpha-7-nikotin-acetylcholin-rezeptoren | |
ATE474840T1 (de) | 6-heteroarylpyridoindolon-derivate, ihre herstellung und ihre therapeutische anwendung | |
DE602004015600D1 (de) | Neue imidazolderivative, deren herstellung und deren verwendung als medikament | |
DE602004024538D1 (de) | Sulphonamid benzoxazinonderivate. ihre herstellung und verwendung als medikamente |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |